Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
41 Cards in this Set
- Front
- Back
4 classes of Microtubule Targeting Agents?
|
-vinca alkyloids
-taxanes -epothilones - and estramustine |
|
Vinca alkaloids?
|
vincristine, vinblastine, vindesine, vinorelbine
|
|
Taxanes?
|
paclitaxel, docetaxel
|
|
Epothilones?
|
ixabepilone
|
|
The microtubule structure is composed of?
|
α- and β- heterodimers
|
|
All anti-micotubular drugs are ___phase specific?
|
M phase
|
|
Microtubules are required for?
|
cell shape, transport of vesicles, signaling and mitosis
|
|
Vinca alkyloids based on the catharanthine stucture?
|
vincristine, vinblastine, vindesine,
|
|
Vinca alkyloids based on the induline stucture?
|
vinorelbine
|
|
Vinca alkyloids can cause neuropathy due to?
|
Neuron sensitivity to drugs that affect microtubules
|
|
Vinca alkyloid MOA?
|
binds β-tubulin, blocking its ability to polymerize with α-tubulin into microtubules
• M phase-specific |
|
Vinca alkyloids are extensively metabolized by?
|
CYP-3A4
|
|
Vinca alkyloids require?
|
dose reduction for hepatic impairment
|
|
Vinblastine is given IV and is used to treat?
|
Lymphomas, lung cancer, prostate cancer and melanoma
|
|
Vinblastine is also a strong ______?
|
Vesicant
|
|
Vincristine is given IV and is used to treat?
|
ALL, Lymphoma and pediatric solid timors
|
|
The major toxicity associated with Vincristine is?
|
neuropathy
|
|
True or false, vincristine is not a vesicant like vinblastine?
|
false, vincristine and vinblastine are both vesicants
|
|
True or false, all vinca alkyloids are potent 3A4 inhibitors that require dose adjustments for hepatic impairment?
|
True
|
|
Vinca alkaloids are derivatives of the sap from the _______________?
|
Madagascar periwinkle
|
|
Taxanes are derived from the?
|
Western yew tree
|
|
Modifying the R1 and R2 groups on taxanes makes the drugs more ____and_____.
|
water soluble and poten
|
|
The MOA of taxanes?
|
Bind Beta-tubulin subunit, thus promoting polymerization
|
|
The taxane structure responsible for activity is the?
|
8 membered hexane ring
|
|
Paclitaxel is used to treat?
|
breast, lung, ovarian and head and neck cancer
|
|
The IV vehicle for Paclitaxel is?
|
50%ehtanol and 50% polyethoxylated castor oil (CREMOPHOR EL)
|
|
Albumin bound Paclitaxel is?
|
Abraxane
|
|
Paclitaxel pharmacokinteics are?
|
Non-linear (dose-dependent)
|
|
Myelosuppression due to Paclitaxel treatment is alleviated by?
|
Filgrastim (NEUPOGEN) a granulocyte colony-stimulating factor (G-CSF) analog
|
|
Hypersensitivity reactions (e.g. dyspnea, chest pain,
hypotension) caused by paclitaxel can be prevented by? |
dexamethasone and antihistamines
|
|
The vehicle in Docetaxel is?
|
polysorbate 80
|
|
Docetaxel is used to treat?
|
Lung, prostate, ovarian, breast and head and neck cancers
|
|
The primary clinical toxicity associated with Decetaxel is?
|
Severe myelosuppression
|
|
Ixabepilone MOA?
|
binds to β-tubulin, promoting the
polymerization of microtubules |
|
Ixabepilone is used to treat?
|
breast cancer
|
|
True or false, all plant derived microtubule drugs are potent 3A4 inhibitors?
|
True
|
|
The non-plant derived antimicrotubule is?
|
Estrmustine
|
|
The antimicrotubule in oral dosage is?
|
Estrmustine
|
|
Estramustine is based on?
|
Estradiol
|
|
Estramustine is used to treat?
|
prostate cancer
|
|
The functional group on estramustine is?
|
a nitrogen mustard
-however, estramustine does not function as a nitrogen mustard. The function is that of a microtubule inhibitor |